IRWD — IRONWOOD PHARMACEUTICALS INC

Ownership history in EntryPoint Capital, LLC  ·  6 quarters on record

This page tracks every 13F SEC filing in which EntryPoint Capital, LLC reported a position in IRONWOOD PHARMACEUTICALS INC (IRWD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.15% (2025 Q1)
Avg. % of fund
0.08%
First filed
2023 Q4
Last filed
2025 Q4
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 66,625 -149,218 -69.1% 0.09% $225K $3.37
2025 Q1 ADDED 215,843 +152,930 +243.1% 0.15% $317K $1.47
2024 Q4 ADDED 62,913 +46,248 +277.5% 0.12% $279K $4.43
2024 Q3 ADDED 16,665 +6,076 +57.4% 0.04% $69K $4.12
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    IRWD price (monthly, adj. close)

Other funds also holding IRWD

As of 2025 Q4 — sorted by position size

Sarissa Capital Management LP 3Y 7Y 24.07% Exome Asset Management LLC 1.04% ARMISTICE CAPITAL, LLC 3Y 7Y 0.64% Range Financial Group LLC 3Y 0.5% Persistent Asset Partners Ltd 0.28% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.17% Hillsdale Investment Management Inc. 3Y 7Y 0.11% VIRTUS ADVISERS, LLC 3Y 7Y 0.09% Virtus Investment Advisers, LLC 3Y 7Y 0.07% RENAISSANCE TECHNOLOGIES LLC 3Y 7Y 0.04%
← Back to EntryPoint Capital, LLC Holdings